VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IRIXIRIDEX Corporation
$1.13$20M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIRIXCash Flow

IRIDEX Corporation (IRIX) Cash Flow Statement

30Y historyFree accessUpdated daily

Liquidity remains a primary concern as the company recorded negative free cash flow in nine of the last ten quarters, including a $1.4M outflow in 2026Q1.

IRIX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations-2.3M-2.12M-7.29M-6.75M-9.52M8.22M-3.24M-7.91M-10.03M-3.56M-144K-593K4.01M767K-443K3.05M3.48M6.8M-96K-522K-1.39M2.77M771K5.1M2.52M-3.63M-74K2.86M-2M-100K-1.3M
Operating CF Margin %--4.02%-14.97%-13%-16.71%15.24%-8.91%-18.21%-23.53%-8.57%-0.31%-1.42%9.38%2%-1.31%9.19%7.96%15.73%-0.2%-0.94%-3.86%7.48%2.35%16.1%8.22%-13.33%-0.22%10.69%-8.47%-0.55%-10.48%
Operating CF Growth %263.77%70.97%-8.01%29.14%-215.85%353.85%59.09%21.07%-181.21%-2375.69%75.72%-114.77%423.34%273.14%-114.53%-12.39%-48.82%7181.25%81.61%62.31%-150%259.27%-84.89%102.58%169.3%-4812.16%-102.59%243.1%-1900%92.31%-244.44%
Net Income-3.27M-4.44M-8.91M-9.57M-7.55M-5.22M-6.33M-8.81M-12.81M-12.87M-11.71M474K10.04M2.23M-170K2.14M3.05M2.58M-7.37M-22.27M-5.75M1.67M-402K371K150K-1.27M2.42M1.62M1.7M2.1M1M
Depreciation & Amortization1.54M1.55M1.42M2.03M1.38M1.71M504K688K809K858K648K522K420K490K427K410K515K899K3.22M3.82M542K435K384K703K869K859K893K817K700K400K200K
Stock-Based Compensation562K775K1.24M1.65M1.62M1.63M1.12M1.7M1.8M1.92M1.82M895K972K689K388K478K551K360K322K1.23M1.82M0000000000
Deferred Taxes000000004K-140K8.98M-209K-8.78M61K728K741K1K350K5.59M-1.23M2.49M585K-579K-220K-343K-332K-74K-846K-100K00
Other Non-Cash Items1.16M2.38M328K0187K-2.46M198K74K149K260K337K67K1.31M355K215K280K-3K-12K1.65M19.08M-155K626K1.07M-205K79K552K424K261K0300K0
Working Capital Changes-2.28M-2.38M-1.37M-857K-5.16M12.56M1.27M-1.56M23K6.4M-222K-2.34M52K-3.06M-2.03M-1M-631K2.62M-3.51M-1.15M-323K-547K298K4.45M1.76M-3.44M-3.73M1.01M-4.3M-2.9M-2.5M
Change in Receivables970K-1.15M1.26M358K-237K-2.47M1.86M-271K-1.16M2.16M-865K-1.01M-1.08M-1.93M38K-82K-44K591K469K2.21M396K683K-1.23M1.63M0000000
Change in Inventory-6K2.12M-911K644K-3.02M268K2.38M545K463K2.09M-537K-1.99M1.49M-2.51M-1.38M-981K-210K2.78M2.88M-6.68M-609K-436K-895K2.07M1.71M-3.18M-2.75M-944K-2.5M-2.1M-600K
Change in Payables-295K-1.95M2.49M641K1.09M1.63M-1.45M76K788K-270K-229K465K-520K173K525K66K109K-543K-472K282K-274K-139K204K372K0000000
Cash from Investing-233K-143K-13K-109K-286K-5.56M-93K-509K-827K-782K-1.47M-1.3M-1.03M-253K3.91M-278K-418K-232K-223K-26.48M8.23M-1.46M-2.32M-4M1.85M-1.99M-133K982K-2.4M-4.4M-10.8M
Capital Expenditures-151K-143K-13K-109K-286K-213K-97K-128K-440K-575K-1.06M-875K-568K-380K-394K-203K-193K-232K0-947K-515K-340K-386K-603K-284K-491K-652K-591K-800K-1.8M-600K
CapEx % of Revenue0.29%0.27%0.03%0.21%0.5%0.4%0.27%0.29%1.03%1.38%2.3%2.1%1.33%0.99%1.16%0.61%0.44%0.54%-1.71%1.43%0.92%1.18%1.9%0.93%1.8%1.95%2.21%3.39%9.94%4.84%
Acquisitions00000-5.34M00-387K-382K-406K-423K-459K-383K0-75K000-25.53M-60K340K386K603K0000000
Investments-------------------------------
Other Investing-82K000004K-381K-387K-207K-406K-423K-459K127K4.3M0-225K-223K-223K-947K-515K-340K-386K-603K0000-100K0-100K
Cash from Financing-76K5.96M2.6M-5K-73K9.47M2.47M-156K10.38M2.31M15.36M-1.42M-3.13M1.03M-2.39M-327K-3.43M-2.48M-79K11.85M1.55M968K1.39M254K205K241K560K10K200K300K15.8M
Debt Issued (Net)-4M39K-218K0002.5M000000000-3.52M-2.48M-3.88M9.88M00000000-3K-7K0
Equity Issued (Net)06M3.37M82K21K9.88M0010.47M2.26M14.75M-1.56M-4.67M-426K-2.83M-648K05K05.77M1.55M968K1.39M269K205K241K560K10K248K306K15.8M
Dividends Paid0000000000000000000000000000000
Share Repurchases0000000000-59K-1.56M-4.67M-426K-2.83M-648K000000000-115K0-315K000
Other Financing3.92M-75K-547K-87K-94K-412K-30K-156K-96K44K610K146K1.54M1.46M445K321K88K03.8M-3.8M000-15K0000-45K1K0
Net Change in Cash-2.65M3.64M-4.65M-6.89M-9.93M12.23M-1.03M-8.54M-513K-2.04M13.75M-3.31M-141K1.54M1.11M2.44M-364K4.07M-502K-15.24M8.4M2.27M-160K1.35M4.57M-5.38M353K3.85M200K300K15.8M
Free Cash Flow-2.45M-2.26M-7.3M-6.85M-9.8M8M-3.33M-8.04M-10.46M-4.14M-1.21M-1.47M3.45M387K-837K2.85M3.29M6.57M-96K-1.47M-1.9M2.43M385K4.5M2.23M-4.13M-726K2.27M-2.8M-1.9M-1.9M
FCF Margin %-4.66%-4.29%-15%-13.21%-17.21%14.85%-9.17%-18.51%-24.57%-9.95%-2.61%-3.52%8.05%1.01%-2.47%8.58%7.52%15.19%-0.2%-2.65%-5.29%6.56%1.17%14.2%7.3%-15.13%-2.17%8.49%-11.86%-10.5%-15.32%
FCF Growth %63.98%69.06%-6.48%30.1%-222.5%340.07%58.54%23.16%-152.78%-243.28%17.85%-142.6%790.44%146.24%-129.42%-13.42%-49.95%6939.58%93.46%22.68%-178.19%531.17%-91.44%101.34%154.17%-468.32%-131.97%181.11%-47.37%0%-371.43%
FCF per Share-0.14-0.13-0.44-0.42-0.620.52-0.24-0.59-0.86-0.36-0.12-0.140.330.04-0.090.280.320.73-0.01-0.18-0.250.310.050.610.32-0.61-0.100.33-0.41-0.28-0.30
FCF Conversion (FCF/Net Income)0.75x0.48x0.82x0.70x1.26x-1.57x0.51x0.90x0.78x0.28x0.01x-1.25x0.40x0.34x-0.31x1.17x1.14x2.63x0.01x0.02x0.24x1.66x-1.92x13.75x16.79x2.86x-0.03x1.77x-1.18x-0.05x-1.30x
Interest Paid0000000000000001K57K00000000000000
Taxes Paid0015K0015K014K13K7K22K27K35K00522K439K160K20K4K00000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Persistent cash burn risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Remains Highly Disconnected

According to recent quarterly filings, IRIDEX consistently reports net losses that are frequently exacerbated by operating cash outflows, with the OCF/NI ratio showing extreme volatility and failing to demonstrate a reliable conversion of accounting earnings into actual cash generation for the business over the last ten quarters.

The persistent gap between net income and operating cash flow suggests that the company's accrual-based accounting does not reflect the underlying cash reality of its operations. Investors should monitor this divergence, as it indicates that the business model is currently unable to generate self-sustaining cash flow from its core activities.

Free Cash Flow Remains Consistently Negative

As reported in financial statements, IRIDEX has struggled to maintain positive free cash flow, with the company recording negative FCF in nine of the last ten quarters, highlighting a structural inability to cover operational and capital requirements through its current revenue-generating activities and product mix.

The negative FCF margins, which reached a low of -26.5% in 2024Q3, underscore the difficulty the company faces in scaling its operations toward profitability. This trajectory suggests that without a significant shift in revenue composition or cost structure, the company will continue to rely on external financing to fund its ongoing operations.

Working Capital Volatility Impairs Liquidity

Based on reported figures, IRIDEX exhibits significant swings in working capital, including a notable $1.4M outflow in 2026Q1, which suggests that the company's cash management is highly sensitive to inventory cycles and the timing of collections from its complex network of international distributors.

These fluctuations in working capital appear to be a primary driver of the company's inconsistent cash flow performance. The reliance on distributors may be creating lumpy cash inflows, which complicates the company's ability to maintain a stable liquidity position and meet its short-term obligations.

Minimal Capital Investment Masks Challenges

As indicated by the provided data, IRIDEX maintains a very low capital intensity, with CapEx/Revenue ratios frequently below 0.5%, which suggests that the company is not investing heavily in new production capacity despite its ongoing struggle to achieve operational scale and consistent profitability.

While low capital intensity can sometimes be a positive, in this context, it may indicate that the company is prioritizing survival over necessary investments in innovation or infrastructure. This warrants further investigation into whether the current level of maintenance CapEx is sufficient to support the long-term competitiveness of its laser technology.

IRIX — Frequently Asked Questions

Quick answers to the most common questions about buying IRIX stock.

How much cash does IRIDEX Corporation (IRIX) generate from operations?

IRIDEX Corporation (IRIX) generated $-2.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is IRIDEX Corporation's free cash flow?

IRIDEX Corporation (IRIX) reported negative free cash flow of $2.3M in 2025, indicating capital requirements exceeded cash from operations.

What is IRIDEX Corporation's capital expenditure (CapEx)?

IRIDEX Corporation (IRIX) spent $0.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.